Fidelity Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.2B Buy
26,341,031
+619,361
+2% +$628M 1.28% 9
2025
Q4
$27.6B Buy
25,721,670
+1,549,858
+6% +$1.48B 1.41% 9
2025
Q3
$18.4B Sell
24,171,812
-1,457,961
-6% -$1.08B 0.96% 12
2025
Q2
$20B Sell
25,629,773
-2,838,895
-10% -$2.21B 1.13% 10
2025
Q1
$23.5B Sell
28,468,668
-2,066,580
-7% -$1.72B 1.5% 8
2024
Q4
$23.6B Sell
30,535,248
-2,501,172
-8% -$2.07B 1.41% 7
2024
Q3
$29.3B Sell
33,036,420
-451,601
-1% -$406M 1.78% 7
2024
Q2
$30.3B Sell
33,488,021
-594,457
-2% -$476M 1.94% 7
2024
Q1
$26.5B Buy
34,082,478
+1,237,058
+4% +$880M 1.78% 7
2023
Q4
$19.1B Buy
32,845,420
+657,948
+2% +$384M 1.47% 8
2023
Q3
$17.3B Sell
32,187,472
-610,817
-2% -$315M 1.49% 9
2023
Q2
$15.4B Buy
32,798,289
+791,013
+2% +$332M 1.29% 9
2023
Q1
$11B Sell
32,007,276
-1,723,192
-5% -$581M 1.01% 10
2022
Q4
$12.3B Buy
33,730,468
+673,823
+2% +$239M 1.23% 10
2022
Q3
$10.7B Buy
33,056,645
+616,979
+2% +$195M 1.11% 11
2022
Q2
$10.5B Buy
32,439,666
+898,976
+3% +$270M 1.05% 11
2022
Q1
$9.03B Buy
31,540,690
+982,907
+3% +$253M 0.72% 14
2021
Q4
$8.44B Sell
30,557,783
-627,630
-2% -$159M 0.62% 19
2021
Q3
$7.21B Buy
31,185,413
+336,852
+1% +$83.1M 0.57% 22
2021
Q2
$7.08B Sell
30,848,561
-3,584
-0% -$720K 0.55% 20
2021
Q1
$5.76B Buy
30,852,145
+5,221,104
+20% +$1.02B 0.49% 24
2020
Q4
$4.33B Sell
25,631,041
-4,228,003
-14% -$631M 0.39% 38
2020
Q3
$4.42B Sell
29,859,044
-133,053
-0.4% -$20.6M 0.45% 30
2020
Q2
$4.92B Buy
29,992,097
+1,954,811
+7% +$300M 0.54% 22
2020
Q1
$3.89B Buy
28,037,286
+13,802,059
+97% +$1.9B 0.54% 23
2019
Q4
$1.87B Buy
14,235,227
+888,413
+7% +$103M 0.21% 89
2019
Q3
$1.49B Buy
13,346,814
+603,776
+5% +$67.2M 0.18% 107
2019
Q2
$1.41B Sell
12,743,038
-1,172,963
-8% -$138M 0.16% 107
2019
Q1
$1.81B Buy
13,916,001
+228,920
+2% +$27.8M 0.22% 83
2018
Q4
$1.58B Buy
13,687,081
+6,242,865
+84% +$697M 0.22% 83
2018
Q3
$799M Buy
7,444,216
+6,255,915
+526% +$625M 0.09% 200
2018
Q2
$101M Buy
1,188,301
+752,864
+173% +$61.8M 0.01% 951
2018
Q1
$33.7M Sell
435,437
-48,753
-10% -$3.92M ﹤0.01% 1476
2017
Q4
$40.9M Sell
484,190
-169,175
-26% -$14.4M ﹤0.01% 1394
2017
Q3
$55.9M Sell
653,365
-418,062
-39% -$34.3M 0.01% 1253
2017
Q2
$88.2M Sell
1,071,427
-894,233
-45% -$73M 0.01% 1041
2017
Q1
$165M Buy
1,965,660
+660,441
+51% +$52.9M 0.02% 773
2016
Q4
$96M Sell
1,305,219
-3,371,698
-72% -$251M 0.01% 1004
2016
Q3
$375M Buy
4,676,917
+696,946
+18% +$55.8M 0.05% 412
2016
Q2
$313M Sell
3,979,971
-2,701,240
-40% -$203M 0.04% 474
2016
Q1
$481M Sell
6,681,211
-2,888,254
-30% -$219M 0.07% 304
2015
Q4
$806M Buy
9,569,465
+3,351,342
+54% +$278M 0.11% 188
2015
Q3
$520M Buy
6,218,123
+104,250
+2% +$8.8M 0.07% 286
2015
Q2
$510M Buy
6,113,873
+4,951,251
+426% +$377M 0.07% 332
2015
Q1
$84.5M Buy
1,162,622
+36,222
+3% +$2.58M 0.01% 1103
2014
Q4
$77.7M Sell
1,126,400
-53,003
-4% -$3.58M 0.01% 1134
2014
Q3
$76.5M Sell
1,179,403
-10,231
-0.9% -$648K 0.01% 1098
2014
Q2
$74M Buy
1,189,634
+51,279
+5% +$3.06M 0.01% 1164
2014
Q1
$67M Sell
1,138,355
-3,822,179
-77% -$213M 0.01% 1184
2013
Q4
$253M Sell
4,960,534
-2,808,138
-36% -$141M 0.04% 521
2013
Q3
$391M Sell
7,768,672
-268,974
-3% -$14.1M 0.06% 367
2013
Q2
$395M Buy
+8,037,646
New +$437M 0.06% 357

Other funds holding LLY

Fidelity Investments's LLY Position: Q1 2026 in Review

Fidelity Investments increased its Eli Lilly (LLY) stake by 2.4% in Q1 2026, buying an estimated $628M and bringing the position to 26,341,031 shares worth $24.2B. The position accounts for 1.28% of the portfolio, ranked #9.

Fidelity Investments first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.3B in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fidelity Investments held 26,341,031 shares of Eli Lilly worth $24.2B as of Q1 2026.
  • Fidelity Investments bought 619,361 Eli Lilly shares in Q1 2026, an estimated $628M.
  • Eli Lilly made up 1.28% of Fidelity Investments's portfolio in Q1 2026, its #9 holding.
  • Fidelity Investments first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Fidelity Investments's Eli Lilly position peaked at $30.3B in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.